Scientists and engineers have long sought to harness this power by designing artificial proteins that can perform new tasks, like treat disease, capture carbon, or harvest energy.

Chatbots may significantly lower health systems' operating costs, says a team of doctors, but evaluation and research are critical to keep the trust of both patients and healthcare workers.

Beyond COVID-19, researchers say this is the kind of data analytics that could enhance healthcare for all kinds of diseases with clues hiding in people’s voices.

The team says their findings serve as an important example for introducing digital pathology and deep learning into clinical practice, and their approach could substantially improve cervical cancer screening.

The tool is the industry’s first collection of AI algorithms embedded on a mobile X-ray device and was built in collaboration with UC San Francisco.

By tapping AI to help us understand what makes us stressed and sick, says one stakeholder, we can empower people to prevent potential sickness from occurring in the first place.

Among other things, the projects will enable proactive voice-first technology that uses facial recognition to remind individuals to take their medication.

According to experts, using AI on EHRs to highlight patients at higher risk could reveal who should receive more in-depth screening.

Although some remain skeptical about the potential of AI, it’s clear to see that the pharmaceutical industry is particularly poised to improve and thrive through its usage.